BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Innovasis Announces Successful FDA Clearance For Opteryx Cervical Plate System


7/18/2006 10:54:11 AM

SALT LAKE CITY, July 17 /PRNewswire/ -- Utah-based Innovasis, a research, development and manufacturer of spinal implant devices, has received 510(k) clearance of the Opteryx Cervical Plate System by the United States Food and Drug Administration.

"This is good news for our company as we strive to be a recognized leader in the global spinal business by building intense customer loyalty and improving our products," said Martin Crous, Ph.D., Vice President of Sales and Marketing of Innovasis.

The Innovasis Opteryx Cervical plate System is indicated for stabilizing the cervical spine from C2 to C7 and is intended for use in anterior cervical fixation for the following indications:

* Degenerative Disc Disease (defined as neck pain of discogenic origin with degeneration of the cervical disc) * Spondylolisthesis * Trauma (i.e., fracture or dislocation) * Spinal stenosis * Deformities of curvatures (i.e., scoliosis, kyphosis, and/or lordosis) * Tumor * Pseudoarthrosis, and/or * Previous failed fusion

Other products already cleared by the FDA for Innovasis include the Le Forte System, the Excella-M and PEEK products.

Innovasis offers spinal product implants and instruments that address major pathologies and focus areas of traditional spinal surgery, including deformities, degenerative conditions; trauma and tumors, all of which can result in severe back pain and sometimes paralysis. Spinal implants are aimed at restoring mechanical and neurological function by readjusting vertebral positioning until bone fusion occurs. Founded in 2002, Innovasis is committed to providing surgeons with training, support and excellent customer service.

Innovasis

CONTACT: Martin Crous, Ph.D., Innovasis, +1-801-261-2242,mcrous@innovasis.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES